BNET Industries
Last Fiscal Year Sales:$37.4M
- Private
- US
Dow Jones Description
Cypress Pharmaceutical, Inc., founded in 1993, is a rapidly growing specialty pharmaceutical company that develops, markets and distributes generic prescription and over-the-counter pharmaceutical products to the leading national pharmaceutical wholesalers, chain drug stores, distributors, and other retail merchandisers. Since its inception, Cypress has earned its reputation as one of the most respected pharmaceutical companies in the United States. Cypress offers its customers a diversified product portfolio with over 175 generic pharmaceutical products available for a broad group of therapeutic categories including: - Respiratory - Cough/Cold - Nutritional Supplements - Fluorides/Dental Health - Gastrointestinal - Analgesics - Urinary Tract Products - Women's Health, including Prenatal Vitamins - Pediatrics - Other Cypress' product line is available in a variety of dosage strengths, formulations (controlled-release, soft gels, taste-masking, etc.) and product forms (liquid,...
Marketing Executive
Candace DickenNumber of Employees 20
Contact Information
135 Industrial Blvd
Madison, Mississippi 39110
1 601 856 4393
Peer Companies
NAICS Code Drugs and Druggists' Sundries Merchant Wholesalers: 424210
News & Analysis
Filter by
cypress pharmaceutical inc. - All News and Analysis
Cypress Pharmaceutical, Inc. Receives FDA Approval of Levetiracetam Oral Solution
MADISON, Miss. -- Cypress Pharmaceutical, Inc., announced today that the U.S. Food and Drug Administration FDA has granted final approval of the company's abbreviated new drug application ANDA for Levetiracetam Oral Solution, 100 mg/mL. Levetiracetam Oral Solution, 100 mg/mL is the AB-rated bioequivalent generic to UCB Pharma's Keppra[R] Oral...
Cypress Pharmaceutical
The Food and Drug Administration has approved Cypress Pharmaceutical's 1 mg/ml cetirizine hydrochioride oral solution. The solution is a generic equivalent of Johnson & Johnson's Zyrtec oral solution, and the prescription version is approved for treating symptoms of perennial allergic rhinitis in children between 6 and 23 months of...
Cypress Pharmaceutical, Inc. receives FDA approval of Cetirizine Hydrochloride Oral Solution
MADISON, Miss. -- Cypress Pharmaceutical, Inc., announced today that the U.S. Food and Drug Administration FDA has granted final approval of the company's abbreviated new drug application ANDA for the prescription and over-the-counter versions of Cetirizine Hydrochloride Oral Solution, 1 mg/1 mL. Cypress' Cetirizine HCl Oral Solution is the...
Company Profile for Cypress Pharmaceutical, Inc
Cypress Pharmaceutical, Inc. ("Cypress" or the "Company"), founded in 1993, is a rapidly growing specialty pharmaceutical company that develops, markets and distributes generic prescription pharmaceutical products to the leading national pharmaceutical wholesalers, chain drug stores, distributors, and other retail merchandisers. In 1999, Cypress established a specialty branded business; Hawthorn Pharmaceuticals...
Cypress Pharmaceutical, Inc. and Standard Chem. & Pharm. Co., Ltd. Enter into Development and Marketing Agreement
MADISON, Miss. -- Cypress Pharmaceutical, Inc., today announced that it has entered into a multiple generic product development and marketing agreement with Standard Chem. & Pharm. Co., Ltd., (TAIWAN:1720), a global pharmaceutical company. The agreement encompasses the development and US commercialization of an estimated 3.4 billion dollars in product market...
FAST 40: Generic drug niche grows for Cypress Pharmaceutical
Cypress Pharmaceutical Inc., a specialty pharmaceutical company, based in Madison. After selling products for other pharmaceutical companies for years, Max Draughn took a leap of faith. With only one product to sell generic cough/cold relief medicine he established Cypress Pharmaceutical Inc., in Madison. Since that sultry July day in 1993,...
Cypress Pharmaceutical Inc
MADISON, Miss. -- Cypress Pharmaceutical Inc., a rapidly growing pharmaceutical company, is committed to a mission of providing quality, integrity and service in generic pharmaceuticals. Cypress, which was established in 1993, offers its customers more than 200 products covering a broad array of therapeutic categories in a variety of...
Focus Private Companies: Cypress Pharmaceutical adding specialty sales force
MADISON - In August, Madison-based Cypress Pharmaceutical was awarded the Cardinal Health Supplier Quality Award for the sixth time, becoming only one of nine companies in the nation's pharmaceutical industry to have achieved the prestigious award as many times.
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Candace Dicken | Marketing Executive |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Jennifer Mulloy | Board Director |
| Jonathan M. Goldstein | Board Director |
| Organization | Position | Status |
|---|---|---|
| Cypress Pharmaceutical, Inc. | Marketing Executive | Current |
| Organization | Position | Status |
|---|---|---|
| TA Associates, Inc. | Board of Directors | Current |
| Cypress Pharmaceutical, Inc. | Board Director | Current |
| One Call Medical, Inc. | Board Director | Current |
| TA Associates, Inc. | Director | Current |
| Millennium Pharmaceuticals, Inc. | Corporate Development | Former |
| Robertson, Stephens & Company | Associate | Former |
| National Imaging Associates Inc. | Board Observer | Former |
| Harvard Business School | MBA | Former |
| Stanford University | AB | Former |
| Organization | Position | Status |
|---|---|---|
| TA Associates, Inc. | Managing Director | Current |
| Wellmed Medical Management, Inc. | Board Director | Current |
| Logistics Health Incorporated | Board Director | Current |
| Cypress Pharmaceutical, Inc. | Board Director | Current |
| J&B Software Inc. | Board Director | Current |
| Biogen, Inc. | NA | Former |
| Unique Instruments, Inc. | Board Director | Former |
| Andovernet | Board Director | Former |
| New England Venture Capital Association | Board Member | Former |
| Harvard Business School | MBA | Former |
| Massachusetts Institute of Technology | SB Chemical Engineering | Former |
Industry Transcripts by Seeking Alpha
-
Neogen Corporation F2Q10 (Qtr End11/30/09) Earnings Call Transcript
on Dec 18, 2009about NEOG
-
Schiff Nutrition International, Inc. F2Q10 (Qtr End 11/30/09) Earnings Call Transcript
on Dec 17, 2009about WNI
-
Martek Biosciences Corporation F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 16, 2009about MATK
-
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about PPHM
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes


